Injector Piston Assembly with Compressible Section for Lower Break Loose Force

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing injectors, particularly prefilled syringes, face challenges with high break loose force (BLF) due to increased interaction between piston sealing elements and the inner wall over time, especially in glass syringes with wide tolerances, leading to high static friction and user discomfort, and traditional lubricants can be harmful to pharmaceutical compositions.

Innovation Solution

The injector features a piston assembly with a compressible section between an actuating piston element and a passive piston element linked by a resilient frame, reducing BLF by evenly distributing the force through differential movement of sealing elements, eliminating the need for lubrication, and accommodating glass syringe tolerances.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If traditional lubrication is used to reduce friction, then glide force is reduced, but break loose force increases due to protein aggregation and harmful effects on pharmaceutical compositions

Engineering Contradiction:
Improveglide forceVSAvoidprotein aggregation
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The invention removes the lubricant from the system entirely, extracting the harmful element (silicone lubricant) that causes protein aggregation while still achieving low friction through the compressible section mechanism. The piston assembly operates without any lubricating substance, eliminating the harmful interaction between lubricant and pharmaceutical composition.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The compressible section acts as an intermediary mechanism between the piston element and the liquid pharmaceutical composition. This intermediate structure provides the necessary friction reduction and smooth operation without requiring traditional lubricants, thereby preventing protein aggregation and harmful effects on the pharmaceutical composition.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If piston sealing elements interact with inner wall over time, then sealing is maintained, but break loose force increases due to stick effect

Engineering Contradiction:
ImprovesealingVSAvoidbreak loose force
Core Design Contradiction:
ReliabilityVSForce

Solution Approach 1:

The invention introduces a dynamic compressible section that adapts to the interaction between piston sealing elements and the inner wall over time. This dynamic structure maintains sealing reliability while preventing excessive stick effect buildup, allowing the piston to move smoothly even after long storage periods without requiring high break loose force.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The compressible section changes its physical parameters (compression, elasticity) in response to the interaction between sealing elements and the inner wall. This parameter change allows the system to maintain effective sealing while reducing the stick effect that would otherwise increase break loose force over time.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If piston diameter is increased to ensure sealing in glass syringes, then container closure integrity is improved, but break loose force increases due to tighter fit

Engineering Contradiction:
Improvecontainer closure integrityVSAvoidbreak loose force
Core Design Contradiction:
ReliabilityVSForce

Solution Approach 1:

The invention segments the piston assembly into multiple elements (first piston element, second piston element) with a compressible section between them. This segmentation allows each element to have optimized dimensions for sealing while the compressible section manages the friction and break loose force, preventing the need for a single large-diameter piston.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The compressible section serves as an intermediary that mediates between the sealing requirements and the friction generation. It allows the piston elements to maintain adequate sealing contact with the glass syringe wall while the compressible material absorbs excess friction, preventing high break loose force even with larger piston dimensions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution provides a smoother user experience with reduced BLF comparable to glide force, ensuring efficient sealing and long-term storage without lubricant-related issues, particularly suitable for prefilled syringes.

Implementation Method 1

a compressible section between an actuating piston element and a passive piston element, which piston elements abut the inner wall of the cylinder at abutting interfaces thereby sealing the compressible section when the piston assembly is inserted in the cylinder

Methodology Applied
Scientific EffectElasticity: Elasticity

Implementation Method 2

a resilient frame linking the actuating piston element to the passive piston element

Methodology Applied
Scientific EffectMechanical Force: Mechanical Force

Implementation Method 3

thereby sealing the compressible section when the piston assembly is inserted in the cylinder

Methodology Applied
Scientific EffectFriction: Friction

Data Source

PatentUS20250229032A1Injector with reduced break loose force
Publication Date: 2025.07.17 INJECTO
  • US20250229032A1 patent drawing
  • US20250229032A1 patent drawing
  • US20250229032A1 patent drawing

AI summary

The present invention relates to an injector for delivery of a pharmaceutical composition, the injector comprising—a cylinder extending along a longitudinal axis, the cylinder having an inner wall, an outer wall, and an outlet at an outlet end opposite an actuating end, a piston assembly comprising a compressible section between an actuating piston element and a passive piston element, which piston elements abut the inner wall of the cylinder at abutting interfaces thereby sealing the compressible section when the piston assembly is inserted in the cylinder, the compressible section comprising a compressible fluid and a resilient frame linking the actuating piston element to the passive piston element. The injector is suited for pre-filled injectors allowing long term storage of protein based pharmaceutical compositions.